Lundström Simon, Agger Erik, Lydrup Marie-Louise, Jörgren Fredrik, Buchwald Pamela
Department of Surgery, Skåne University Hospital, Malmö, Sweden.
Department of Clinical Sciences, Lund University, Lund, Sweden.
Br J Surg. 2024 Dec 24;112(1). doi: 10.1093/bjs/znae309.
BACKGROUND: Tumour deposits are a prognostic factor for overall survival and distant metastasis in lymph node-negative colorectal cancer. However, the current TNM staging system does not account for the presence of tumour deposits in lymph node-positive colorectal cancer, or for the presence of multiple deposits. This study aimed to investigate the prognostic effect of tumour deposit count in patients with colorectal cancer. METHODS: Patients who underwent curative surgery for colorectal cancer between 2016 and 2019 were identified nationwide from the Swedish Colorectal Cancer Registry. Patients with undisclosed tumour deposit status/count and stage IV disease were excluded. Univariable and multivariable Cox regression analyses were used to assess the prognostic effect of tumour deposit count on overall survival and distant metastasis adjusted for age, sex, neoadjuvant treatment, and number of positive lymph nodes. RESULTS: Of 18 913 patients assessed, 14 154 patients were analysed with tumour deposits (TDs) present in 1702 (12%) patients. Patients were stratified by tumour deposit count (0, 1, 2, 3, 4, and ≥5 TDs). Increased tumour deposit count was associated with decreased 5-year overall survival (79%, 70%, 61%, 66%, 50%, 49%) and increased 5-year risk for distant metastasis (14%, 26%, 35%, 41%, 48%, 54%) respectively. Tumour deposit count remained an independent negative prognostic factor after multivariable Cox regression analysis. CONCLUSION: Tumour deposit count is a negative prognostic predictor of both overall survival and distant metastasis in colorectal cancer, independent of positive lymph nodes or neoadjuvant treatment. These findings suggest that tumour deposit count should be integrated into the TNM staging regardless of lymph nodes status to improve prognostic accuracy.
背景:肿瘤沉积物是淋巴结阴性结直肠癌总生存期和远处转移的一个预后因素。然而,当前的TNM分期系统未考虑淋巴结阳性结直肠癌中肿瘤沉积物的存在情况,也未考虑多灶性肿瘤沉积物的存在。本研究旨在调查肿瘤沉积物数量对结直肠癌患者的预后影响。 方法:从瑞典结直肠癌登记处全国范围内确定2016年至2019年间接受结直肠癌根治性手术的患者。排除肿瘤沉积物状态/数量未公开以及IV期疾病患者。采用单变量和多变量Cox回归分析,评估在调整年龄、性别、新辅助治疗和阳性淋巴结数量后,肿瘤沉积物数量对总生存期和远处转移的预后影响。 结果:在评估的18913例患者中,14154例患者存在肿瘤沉积物(TDs),其中1702例(12%)患者有肿瘤沉积物。患者按肿瘤沉积物数量(0、1、2、3、4和≥5个TDs)分层。肿瘤沉积物数量增加分别与5年总生存率降低(79%、70%、61%、66%、50%、49%)和5年远处转移风险增加(14%、26%、35%、41%、48%、54%)相关。多变量Cox回归分析后,肿瘤沉积物数量仍然是一个独立的不良预后因素。 结论:肿瘤沉积物数量是结直肠癌总生存期和远处转移的不良预后预测指标,独立于阳性淋巴结或新辅助治疗。这些发现表明,无论淋巴结状态如何,肿瘤沉积物数量均应纳入TNM分期,以提高预后准确性。
Cochrane Database Syst Rev. 2018-2-6
Cochrane Database Syst Rev. 2022-9-26
Health Technol Assess. 2006-9
Cochrane Database Syst Rev. 2022-5-20
Cochrane Database Syst Rev. 2008-7-16
Cochrane Database Syst Rev. 2018-7-12
Ann Gastroenterol Surg. 2023-1-12
Int J Colorectal Dis. 2023-3-10
World J Gastrointest Oncol. 2022-9-15